Target intelligence / Profile preview

microRNA 527 (miR-527)

Target
miR-527
Molecular classification
MicroRNA, Non-coding RNA, Regulatory RNA, Small RNA
01

Overview

microRNA 527 (miR-527) is a small non-coding RNA molecule belonging to the microRNA family, which regulates gene expression at the post-transcriptional level by binding to the 3′-untranslated regions (UTRs) of specific target mRNAs, leading to their degradation or inhibition of translation[4]. miR-527 has been implicated in various cancers, sometimes acting as a tumor suppressor and in other contexts as an oncogene. It is involved in the regulation of cell proliferation, cell cycle control, migration, invasion, and cancer stemness by repressing different targets including UBE2A, PHLPP2, Sp1, BRF2, PHF21B, and FBXW7[1][2][3][5]. Its expression and function appear highly context- and tissue-dependent. No drugs directly target miR-527 currently, but manipulating its expression is being explored for cancer therapy and prognosis.

Other names
hsa-miR-527MIR527MIRN527hsa-mir-527
02

Mechanism of action

Binds to 3′-UTRs of mRNAs to repress translation or induce degradation (via Argonaute/RISC complex)[4] Acts as a post-transcriptional regulator for specific gene targets such as UBE2A, PHLPP2, Sp1, BRF2, PHF21B, FBXW7[1][2][3][5]

03

Biological functions

Regulation of gene expression (post-transcriptional)Cell proliferationCell cycle regulationCell migration and invasionStemness regulationTumor suppression (context-dependent)Oncogenic activity (context-dependent)
04

Disease associations

Cancer (Hepatocellular carcinoma, Esophageal squamous cell carcinoma, Non-small cell lung carcinoma, Bladder cancer, Gastric cancer, Glioma)[1][2][3][5]Other (as typical of miRNA function, potentially broad but not robustly described in other diseases in current results)
05

Safety considerations

Not directly defined as a drug target, but altering microRNA levels systemically can have broad and unpredictable gene expression effects, raising safety concerns about off-target effects and systemic toxicity (typical for microRNA therapeutics)
06

Biomarkers

Expression level of miR-527 in tumor tissues as prognostic indicator (proposed for several cancers)[1][2][5]

Beyond the preview

Go deeper on microRNA 527 (miR-527).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 527 (miR-527).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call